Future of Targeted Agents in Metastatic Colorectal Cancer

Colorectal Cancer - United Kingdom
doi 10.2217/crc.12.52
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

New Therapeutic Agents for Metastatic Colorectal Cancer: Literature Review

Colorectal Oncology
2018English

BRAF-mutated Metastatic Colorectal Cancer Between Past and Future

British Journal of Cancer
Cancer ResearchOncology
2015English

HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Novel Chemosensitive Single-Nucleotide Polymorphism Markers to Targeted Regimens in Metastatic Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2011English

Immunodivergence in Metastatic Colorectal Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Pcn143 - Health Economic Evaluation of Biologic Agents for Metastatic Colorectal Cancer Patients in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

PLoS ONE
Multidisciplinary
2015English

First-Line Therapy for Metastatic Colorectal Cancer: Current Perspectives and Future Directions

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy